J&J Vision’s Menziuso sees huge opportunity; Boston Scientific’s view of AI-driven Diagnostics

In this episode of the DeviceTalks Weekly podcast, MassDevice Editor Chris Newmarker speaks with Peter Menziuso, Johnson & Johnson company group chair for Vision, about the company’s strategy to advance vision care.

J&J MedTech’s Vision business already represents one-sixth of the company’s $32 billion in annual medtech revenue, and new innovations are on the way to reach even more people with vision impairments. Recent launches include the Acuvue Oasys Max multifocal lens for astigmatism and the Tecnis Odyssey next-generation intraocular lens for cataract patients.

This episode is sponsored by InterPower. Learn more at InterPower.com.

Before that interview, DeviceTalks Managing Editor Kayleen Brown talks AI and diagnostics with Dennis Cheng, vice president of Cardiac Diagnostic Solutions at Boston Scientific, as part of our FOMO series.

Newly minted Senior Editor Sean Whooley joins Newmarker and Host Tom Salemi to break down the week’s biggest headlines — including updates from Medtronic, Biotronik, CardioFocus, Cardiosense, and Dexcom. We’ll also review the new MassDevice Diabetes Technology Innovations Report.

Thanks for listening to the DeviceTalks Weekly podcast.

***

Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe